RBC Capital lowered the firm’s price target on OmniAb (OABI) to $4 from $7 and keeps an Outperform rating on the shares. The company provided ...

DURAVYU™ has been conditionally accepted by the FDA as the proprietary name for EYP-1901. DURAVYU is an investigational product; it has not been approved by the FDA. FDA approval and the timeline for ...

Barclays on Wednesday became the latest brokerage after Goldman Sachs and RBC Capital Markets to slash its year-end target ...

GFL Environmental Inc. (NYSE: GFL) (TSX: GFL) ("GFL" or the "Company") today announced the pricing of the previously ...

Oil prices settled higher on Friday and recorded a second consecutive weekly gain as fresh US sanctions on Iran and the ...

Another source that is highly strategic for manufacturers in today’s political and economic environment, yet not quite part of the standard capital alternatives playbook, is the sale leaseback. As the ...

EV producers like Tesla and Rivian have boosted their profits by selling emissions credits to makers of gas vehicles.

Its measure of consumer sentiment sank for a third straight month due mostly to concerns about the future. “We still view ...

DBS Group, Southeast Asia's biggest bank, has raised $2 billion through a multi-tranche U.S. dollar senior bond issuance for ...

Investing.com -- RBC Capital Markets upgraded Wells Fargo & Co to "Outperform," saying the recent decline in the bank’s stock presents a good entry point for investors. RBC expects Wells Fargo ...

The latest price target for Palantir Technologies (NASDAQ:PLTR) was reported by Loop Capital on March 13, 2025. The analyst firm set a price target for $125.00 expecting PLTR to rise to within 12 ...

In line with this, the private wealth management company has unveiled new private trust services along with a refreshed logo. The move showed Areca Capital’s dedication to innovation and ...